EXETER, N.H.--(BUSINESS WIRE)--April 10, 2006--Bentley Pharmaceuticals, Inc. (NYSE: BNT - News), a specialty pharmaceutical and drug delivery company, announced today that John A. Sedor, President of the Company and Michael Price, Vice President and CFO, will present at the UBS Global Specialty Pharmaceuticals Conference taking place at the Grand Hyatt in New York City. The presentation is scheduled for Tuesday, April 25, 2006 at 8:00 AM.
